SynthesisBMC endocrine disorders2025
The prevalence of all stype of diabetes and pre‑diabetes in the Eastern Mediterranean countries: a meta‑analysis study.
Synthesis in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Patient-Centered Diabetes Care Through an Ethical Lens: Associations with Patient Satisfaction and Patient-Reported Outcomes in Saudi Primary Healthcare.Healthcare (Basel, Switzerland) · 2026Article
- Cardiometabolic Effects of Semaglutide in Individuals with Type 2 Diabetes in the United Arab Emirates: Real-World 12-Month Outcomes and Predictors of Response.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026Article
- Association Between Maternal Serum 25-Hydroxyvitamin D Concentrations and Gestational Diabetes Mellitus in Women Undergoing Diagnostic 100-g Oral Glucose Tolerance Testing.Journal of clinical medicine · 2026Article
- Article
- Review
- Cross-Cultural Adaptation and Validation of the Simplified Diabetes Knowledge Test (Arabic Version) for Insulin-Dependent Diabetic Patients: A Cross-Sectional Study in Iraq.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimGiven the high prevalence, incidence, and impact on Disability-Adjusted Life Years (DALYs) associated with diabetes, coupled with the limited availability of meta-analysis studies examining its prevalence in the Eastern Mediterranean Regional Office (EMRO) countries, the main objective of this study was to investigate the combined prevalence of type 1 (T1DM) and type 2 diabetes (T2DM), gestational diabetes, and pre-diabetes within the Eastern Mediterranean region.
methodsTo implement a comprehensive search strategy aligned with the objectives of this meta-analysis, searches were conducted across international databases, including PubMed (Medline), Scopus, Embase, Web of Science, and the Cumulative Index to Nursing and Allied Health Literature (CINHAL) from January 1967 to December 2022. The quality of the selected studies was assessed using the JBI critical appraisal checklist for analytical cross-sectional studies. Subgroup analyses were conducted based on factors such as gender, country, geographic area, criteria for diagnosis, and Gross Domestic Product (GDP) level.
resultsOut of 5,238 primary studies initially screened, 186 articles were included in the meta-analysis. The pooled prevalence of diabetes was found to be 15% (95% CI: 13 - 16%), of which 6% (95% CI: 4 - 7%) represented undiagnosed cases, while 8% (95% CI: 7 - 10%) were known cases. The prevalence of T2DM was 13% (95% CI: 11 - 16%), while T1DM was found to have a prevalence of 1% (95% CI: 1 - 2%). Pre-diabetes had a pooled prevalence of 15% (95% CI: 13 - 18%), with impaired glucose tolerance (IGT) and impaired fasting glycemia (IFG) representing 9% (95% CI: 7 - 11%) and 8% (95% CI: 6 - 11%) of cases, respectively. The prevalence of gestational diabetes mellitus (GDM) was found to be 11% (95% CI: 9 - 14%) in the EMRO.
conclusionThe findings emphasize the need for enhanced healthcare programs, including early screening, effective management, and lifestyle interventions such as healthy eating and physical activity. The analysis also highlights the importance of considering socioeconomic factors like urbanization, diet changes, and healthcare access when developing diabetes prevention and management strategies. The results call for policymakers and healthcare providers to collaborate in addressing the growing public health burden of diabetes in the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.